{
    "clinical_study": {
        "@rank": "35226", 
        "arm_group": [
            {
                "arm_group_label": "Atlantic Western chips", 
                "arm_group_type": "Experimental", 
                "description": "deep fried potato chips"
            }, 
            {
                "arm_group_label": "Dakota Pearl chips", 
                "arm_group_type": "Experimental", 
                "description": "deep fried potato chips"
            }, 
            {
                "arm_group_label": "Andover Ontario chips", 
                "arm_group_type": "Experimental", 
                "description": "deep fried potato chips"
            }, 
            {
                "arm_group_label": "white bread with margarine", 
                "arm_group_type": "Experimental", 
                "description": "energy control"
            }, 
            {
                "arm_group_label": "white bread", 
                "arm_group_type": "Experimental", 
                "description": "control"
            }
        ], 
        "brief_summary": {
            "textblock": "Potato is one of the world's most popular foods and is widely accepted as a staple food. The\n      objective of this study is to determine the effect of consuming potato chips from different\n      cultivars on blood glucose, subjective appetite and food intake. It is hypothesized that the\n      chips produced from various potato cultivars will differ in their effect on blood glucose,\n      satiety and food intake."
        }, 
        "brief_title": "The Food Intake, Satiety and Blood Glucose After Ingestion of Potato Chips Produced From Three Potato Cultivars", 
        "condition": [
            "Obesity", 
            "Overweight", 
            "Diabetes", 
            "Metabolic Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Overweight", 
                "Metabolic Syndrome X"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy men with a body mass index (kg/m2) of 20-24.9\n\n        Exclusion Criteria:\n\n          -  smocking, medication, breakfast skipping, restrained eating"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "December 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02014220", 
            "org_study_id": "Potato study 3: cultivar chips"
        }, 
        "intervention": {
            "arm_group_label": [
                "Atlantic Western chips", 
                "Dakota Pearl chips", 
                "Andover Ontario chips", 
                "white bread with margarine", 
                "white bread"
            ], 
            "intervention_name": "dietary treatment", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5S 3E2"
                }, 
                "name": "Department of Nutritional Sciences"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "other_outcome": {
            "description": "Subjective appetite will be measured with visual analogue scales at 0 min immediately before the treatment (baseline) and at 15, 30, 45, 60, 90 and 120 min after the treatment.", 
            "measure": "satiety", 
            "safety_issue": "No", 
            "time_frame": "120 min"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Glycaemic response will be measured before the treatment (baseline) and at 15, 30, 45, 60, 90 and 120 min after the treatment. The glucose concentration will be measured in capillary blood using portable glucose meter.", 
            "measure": "blood glucose", 
            "safety_issue": "No", 
            "time_frame": "120 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02014220"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Toronto", 
            "investigator_full_name": "G. Harvey Anderson", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Ad libidum food intake will be measure at 120 min using test pizza meal. The amount of consumed test meal (g) will be converted to the energy (kcal).", 
            "measure": "food intake", 
            "safety_issue": "No", 
            "time_frame": "120 min"
        }, 
        "source": "University of Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Toronto", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}